Jones Financial Companies
CSTL icon

Jones Financial Companies’s Castle Biosciences CSTL Stock Holding History

Jones Financial Companies’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.34K Buy
343
+93
+37% +$2.07K ﹤0.01% 3864
2026
Q1 		$5.88K Sell
250
-265
-51% -$8.68K ﹤0.01% 3778
2025
Q4 		$20K Buy
515
+490
+1,960% +$15.8K ﹤0.01% 2931
2025
Q3 		$568 Hold
25
– – ﹤0.01% 4016
2025
Q2 		$509 Hold
25
– – ﹤0.01% 3804
2025
Q1 		$499 Hold
25
– – ﹤0.01% 3509
2024
Q4 		$666 Hold
25
– – ﹤0.01% 3198
2024
Q3 		$697 Buy
+25
New +$636 ﹤0.01% 2856

Other funds holding CSTL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $5.69B AUM 259.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jones Financial Companies's CSTL Position: Q2 2026 in Review

Jones Financial Companies increased its Castle Biosciences (CSTL) stake by 37% in Q2 2026, buying an estimated $2.07K and bringing the position to 343 shares worth $8.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3864.

Jones Financial Companies first reported a position in CSTL in Q3 2024 and has held it in 8 quarters since. The position peaked at $20K in Q4 2025. 177 funds tracked by Wall St. Rank hold CSTL as of Q2 2026.

  • Jones Financial Companies held 343 shares of Castle Biosciences worth $8.34K as of Q2 2026.
  • Jones Financial Companies bought 93 Castle Biosciences shares in Q2 2026, an estimated $2.07K.
  • Castle Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3864 holding.
  • Jones Financial Companies first reported a position in Castle Biosciences in Q3 2024 and has held it in 8 quarters since.
  • Jones Financial Companies's Castle Biosciences position peaked at $20K in Q4 2025.
  • 177 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.